The FDA has agreed to speed up review of donanemab, but the Centers for Medicare and Medicaid Services is moving to limit reimbursement for drugs in this class to only patients in clinical trials.
The Indianapolis-based drugmaker said the antibody is effective against the omicron variant and it has already manufactured several hundred thousand doses. The deal calls for the federal government to pay Lilly more than $720 million.
The Indianapolis-based pharmaceutical company said the facility is part of its strategy to advance RNA-based therapeutics and builds on its acquisition of Prevail Therapeutics, a gene therapy company based in New York.
Elanco Animal Health Inc. said Thursday morning that revenue climbed 46% last year and its net loss narrowed, strengthening its financial position as it prepares to break ground this spring on a new $100 million headquarters in Indianapolis.
Nearly 30 million Americans have diabetes, and more than 6 million use insulin to keep their blood sugars under control. It’s an old drug, refined over the years, that has seen relentless price increases.
Indiana-based firms are struggling with how to protect their employees and their business interests in those countries while also condemning the Russian government’s actions.
While we’ll all likely be grumbling about high gasoline prices for some time to come, President Joe Biden’s decision this week to ban Russian oil imports was unquestionably the right move.
Additionally, the pharmaceutical giant said in a statement that it had “suspended all investments, promotional activities, and new clinical trials in Russia.”
For the third year in a row, an investor is proposing that the pharmaceutical company scrap the tradition of combining the role of chief executive officer and board chair.
An unnamed Cummins shareholder is proposing that the company separate its CEO and board chair roles, which are both held by Tom Linebarger. Cummins is recommending that shareholders vote against this proposal.
The Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms.
The proposal would require disclosure of risks climate change pose to companies and the amount of greenhouse gas emissions produced by companies and by their supply chain.
Former Indiana University Health executive Ryan Kitchell will replace former chair and Indiana Higher Education Commissioner Teresa Lubbers, who announced she would step down from both roles in November.
Local officials and not-for-profits are exploring the potential sale of carbon credits to finance the maintenance and preservation of city parks, and to purchase land for more.
